gradient/postop Hypoxemia • Decreased difussing capacity/increased closing volume • Intrapulmonary shunting • All aggravated by the GA effects on lung physiology/decreased FRC • Marked bronchial reactivity for up to 6 weeks • Bronchospasm/laryngospasm/stridor-specially subglottic edema if intubated
uncomplicated URI– specially if RAD and intubation required for procedure • Postpone 4-6 weeks for lower airway involvement/ fever more than 38/ purulent discharge malaise and decreased apetite • Risk factors: <1yo/ asthma/prematurity/parental smoking/ ENT surgery • Use mask/LMA when possible • If ETT needed, use a size smaller and appropriate DEPTH of anesthesia • Ultimately, consider Psychosocial variables and use CLINICAL JUDGEMENT!!!
industrialized countries • Chronic inflammatory d/o of medium and small airways • Variable airway obstruction, partially or completely reversible/spontaneously or with treatment • Immune regulatory pathways: IL4/ Interferon G (control IGE Production) • Airway obstruction: smooth muscle spasm/mucosal edema/hypersecretion/mucous plugging • Physiopathologic changes: uneven distribution of ventilation/increased work of breathing/air trapping/V/Qmismatch/hyperinflation/hypoxemia/hypercapnia/resp failure
• Gerd/ temperature changes/exercise/anxiety/URI/mechanical stimulation of the airway • Obesity is a proinflammatory state and independent factor • Severe viral bronchiolitis in infancy/ Respiratory failure in early age/ BPD/CDH/prematurity---rapid drop in saturation without large central airway obstruction (no audible wheezing)
treatement with little effect on HPA axis except for high doses of fluticasone. Oral or parenteral steroids are indicated for acute exacerbations unresponsive to BD therapy • LT antagonists: LT mediate potent SM constriction/ their inhibition increase exhaled NO/ used as maintenance in mod to severe symptoms • B2 adrenergics: increased cAMP with SM relaxation/BD---short acting are indicated for intermittent episodes/acute exacerbations/prevention of exercise induced
baseline/exacerbations/recent illness/PE • Postpone 4-6 weeks if recent bad exacerbation/ URI and elective procedure • Premedication to avoid excitement/ nebulizer/avoid ETT/ lidocaine to blunt reflexes/ avoid ketorolac, morphine, desflurane, atracurium • Extubate DEEP or AWAKE/ BD before extubation, suction secretions thoroughly • Short course of CS (MP 1mg/kg daily) 48 hrs prior
with Chr respiratory insufficiency in premiees • It follows ventilator lung induced injury and oxygen toxicity in babies with RDS • With recent changes in steroids and surfactant therapy, most BPD patients are born at 24-28 weeks • The “new BPD” is referred as O2 dependence for at least 28 postnatal days (prevalence is 20% of babies less than 1500gr) • Evaluation/severity are assessed at 36 weeks PCA and 56d after birth (based on FiO2 needs and vent support)
dependent with or without CPAP or intubation, beyond 4 weeks of age • Persistent airway reactivity and lower airway obstruction (increased thicknesss of airway wall) • Growth failure/chr Hypoxia/Cor Pulmonale • Subglottic stenosis from prolonged intubation/Bronchomalacia/Tracheomalacia • Increased incidence of inguinal hernia (PPV) • Increased postop apnea
in the CFTR gene • 1000 new cases per year in USA (30000 cases)/ most common inherited disorder in whites • Median life expectancy is 37 yo • CFTR regulates Cl and bicarb transport across epithelial cells and epithelial sodium channels (cAMP dependent) • CFTR dysfunction results in impaired exocrine function with abnormal electrolyte and fluid content in the epithelia of lung/pancreas/intestine/hepatobiliary/sweat gland/ vas deferens • Gold st is Cl sweat test, with greater than 60 mEq/lt as diagnostic
r/o atlantoaxial instability • PMH and PE : neck pain/limitation/upper motor dysf • If atlantodens interval greater than 5mm refer to neurosurgery eval • Keep head in neutral position as much as possible
muscle to surrounding connective tissue causing electromechanical dissociation plus instability in cell mb integrity • Myotonic Sd---affects transmission along the muscle mb (abn Na/ K/Ca/Cl channels). Prolonged depol with prolonged contraction • Mitochondrial Myopathies---involves CNS and muscle/ lack of ATP causes weakness and wasting • Myasthenic SD---affect transmission of AP from motor neuron to muscle cell (ach)
airway muscles • Minimize MR/ assume increase sensitivity • Often there is resistance to succ • Watch for fatigue in postop period • Tourniquette release may exacerbate symptoms
rigidity • Might be precipitated by succ or anticholinesterases • Risk of hyperkalemic response with succ • No progression or dystrophic component • Might be precipitated by stress/ cold and pain/ anticholinesterase (not relieved by NDMR) • No true association with MH- GA gases could be used • Episodes of myotonia could be relieved by procainamide/ quinine and GA
meet demands making these pts very vulnerable during the periop period • Shivering from hypothermia represents the greatest threat • Lactic acidosis occurs due to stress • Maintenance fluids with glucose to avoid anaerobic metabolism/do not administer LR/ avoid long fasting periods- monitor glycemia and lactic acidosis, particularly if pt is on a ketogenic diet • Avoid anemia and tourniquettes • Primary complications are resp failure/myocardial and conduction issues/ dysphagia • Use lower doses of GA ,analgesics, sedatives, MR
mechanisms The strongest effect is the inhibition of long chain acylcarnitine esters This is the mechanism implicated in propofol infusion Sd. Limited boluses have been well tolerated LA such as ropi and lidocaine should be prefered over bupi Remifentanyl and dex have been proven useful plus NSAIDS Succ is contraindicated due to the risk of Hyperkalemia and Myolisis
within 3 months • Pulmonary testing before surgery • RSI due to dysphagia and decreased gastric motility • Avoid cardiac depressants • Prepare for RI postoperatively • Risk of hyperkalemia and Rhabdomyolisis with succ (contraindicated) • Avoid triggering agents---Rhabdomyolisis with inhaled agents (not MH)
d/o that results in lack of dystrophin • It progresses to wheelchair dependence by the second decade of life • Profound muscle weakness/Resp failure/cardiomyopathy/conduction defects/occ mild MR • Becker’s is same mutation but less global
chronically weak muscles, prone to damage when exposed to high metabolis stress • McArdle/ King-Denborough/Brody/Schwartz-Jampel • Use of non triggering agents- MH risk!!! • Prolonged observation postop for recurrent weakness
that could facilitate seizures • Most anesthetic agents are safe/ lower MAC • Increased sensitivity to succ no hyperkalemia • Resistant to NDMR and rapid recovery • Pain management is crucial
abnormal B chains of HB S 8% of AA have sickle cell trait (Hb A and S) Homozygous only produce Hb S Bothof the above have a positivedex screen Hb S is less stable and less soluble - rapid denaturation, with RBC damage and rigidity and pathological adherenceand damage to endothelium
Infection and surgical stress are triggering events Dactilytis/ bone and organ infarction/Acute and ChrPain/ACS- fat emboli from necrotic bone marrow/ TIA/ stroke /priapism/ splenic sequestration with schock/aplastic crises/ cholelithiasis-cholcystitis Risk of drug addiction
complications- decrease Hb S to less than 30% or increase Hb to 10g/dl Maintain adequate oxygenation/ thermoregulation/ hydration/ acid - base balance Avoid surgical tourniquettes Pain control is crucial